Investors Hangout Stock Message Boards Logo
  • Mailbox
  • Favorites
  • Boards
    • The Hangout
    • NASDAQ
    • NYSE
    • OTC Markets
    • All Boards
  • Whats Hot!
    • Recent Activity
    • Most Viewed Boards
    • Most Viewed Posts
    • Most Posted
    • Most Followed
    • Top Boards
    • Newest Boards
    • Newest Members
  • Blog
    • Recent Blog Posts
    • Recently Updated
    • News
    • Stocks
    • Crypto
    • Investing
    • Business
    • Markets
    • Economy
    • Real Estate
    • Personal Finance
  • Market Movers
  • Interactive Charts
  • Login - Join Now FREE!
  1. Home ›
  2. Stock Message Boards ›
  3. Stock Boards ›
  4. CytoDyn Inc (CYDY) Message Board

Optics: 2018 / 2024: U.S. Market Potential: HA

Message Board Public Reply | Private Reply | Keep | Replies (0)                   Post New Msg
Edit Msg () | Previous | Next


Post# of 155592
(Total Views: 743)
Posted On: 08/22/2024 3:33:25 AM
Posted By: My69z
Optics: 2018 / 2024:

U.S. Market Potential:
HAART failures:
70,000 pts with two or more drug class resistances

70,000 pts x 70% (R5-HIV strain) = 49,000 HIV pts R5 eligible

49,000 pts x $24,000
(current market pricing) = ~ $1.2 billion

Label Expansion Switch to Monotherapy Maintenance:
U.S. Market Potential
Target population (suppressed VL) = 17.5% of 1.3 million HIV+ = 227,500

227,500 pts x 70% (R5-HIV) = 159,250 pts

159,250 pts x $24,000
(current market pricing) = ~ $3.8 billion

BLA Submission for HIV Combination Therapy: 3Q 2018
______________
Now compare that 2018 market potential, to this 2024:

https://www.cytodyn.com/pipeline
______________

Alzheimer’s market alone, is a $2T growth projection, from current $1T.

Other than wanted to look back refresh/compare/appreciate for myself of April 2018 to 2024, & anyone else of same timeframe or longer --- (which sure aren't very many) --- & to really hit home for anyone, the significance of when Dr. J said 2024 will be a pivotal year.

*CEO in November 2023
*Lifting FDA’s hold March 2024

Stunning work, that all of Mgt has done with Cytodyn.

To go from hyping "$5b market potential" & "filing" a BLA.

To Leronlimab today being developed up to it's true potential of what it is:

a platform drug with no toxicity or drug interaction.

Find a pharma company who has ever had, this kind of turnaround potential --
even with or without an FDA hold period.

My 2018 vision doesn't recognize today's Cytodyn & @ times still seemed like a dream.

With funds raised, trial updates & new job openings have solidly brought me out of 2018 & into:

"yes, all things true, is really happening"

100% comfortably day to day on that.

That's extremely rare in the stock market.

Thanks to what Leronlimab is:
A rarity, that will safely help humanity.


(7)
(0)




CytoDyn Inc (CYDY) Stock Research Links


  1.  
  2.  


  3.  
  4.  
  5.  






Investors Hangout

Home

Mailbox

Message Boards

Favorites

Whats Hot

Blog

Settings

Privacy Policy

Terms and Conditions

Disclaimer

Contact Us

Whats Hot

Recent Activity

Most Viewed Boards

Most Viewed Posts

Most Posted Boards

Most Followed

Top Boards

Newest Boards

Newest Members

Investors Hangout Message Boards

Welcome To Investors Hangout

Stock Message Boards

American Stock Exchange (AMEX)

NASDAQ Stock Exchange (NASDAQ)

New York Stock Exchange (NYSE)

Penny Stocks - (OTC)

User Boards

The Hangout

Private

Global Markets

Australian Securities Exchange (ASX)

Euronext Amsterdam (AMS)

Euronext Brussels (BRU)

Euronext Lisbon (LIS)

Euronext Paris (PAR)

Foreign Exchange (FOREX)

Hong Kong Stock Exchange (HKEX)

London Stock Exchange (LSE)

Milan Stock Exchange (MLSE)

New Zealand Exchange (NZX)

Singapore Stock Exchange (SGX)

Toronto Stock Exchange (TSX)

Contact Investors Hangout

Email Us

Follow Investors Hangout

Twitter

YouTube

Facebook

Market Data powered by QuoteMedia. Copyright © 2025. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges).
Analyst Ratings & Earnings by Zacks. RT=Real-Time, EOD=End of Day, PD=Previous Day. Terms of Use.

© 2025 Copyright Investors Hangout, LLC All Rights Reserved.

Privacy Policy |Do Not Sell My Information | Terms & Conditions | Disclaimer | Help | Contact Us